MicroRNA-222 Expression and Its Prognostic Potential in Non-Small Cell Lung Cancer

Table 2

Multivariate analyses for prognostic factors in patients with non-small cell lung cancer.

Variables	Hazard ratio (95% CI)	𝑃 value
Age (<60 versus ≥60)	0.98 (0.81–1.39)	0.11
Sex distribution (male versus female)	1.31 (0.77–1.89)	0.17
TNM stage (I-II versus III)	0.76 (0.65–0.89)	0.009
Regional lymph node involvement (absent versus present)	0.68 (0.39–0.77)	0.007
miR-222 (high versus low)	3.31 (1.97–5.58)	<0.001

CI: confidence interval.